David N. Bell
Vice President
Drug Development
Therapure Biopharma Inc
Canada
Biography
David's primary responsibility at Therapure is the development of a pipeline consisting of new protein and cell-culture-based product candidates for the treatment of anemia, cancer and infectious diseases. He also leads the team offering development services for new product entries. Prior to joining the company in 1994, David was Group Leader of Cancer Biology at BioChem Therapeutic, Inc. and before that, Laboratory Director of the BioVentures Division of FAA in Worcester, Massachusetts, USA. He received his PhD from the Department of Medicine at McGill University in 1988 and completed a postdoctoral fellowship at the McGill Cancer Centre.
Research Interest
development of a pipeline consisting of new protein and cell-culture-based product candidates for the treatment of anemia, cancer and infectious diseases
